BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kazemi A, Majidinia M, Jaafari A, Ayatollahi Mousavi SA, Zarei Mahmoudabadi A, Alikhah H. Etiologic Agents of Otomycosis in the North-Western Area of Iran. Jundishapur J Microbiol 2015;8:e21776. [PMID: 26495108 DOI: 10.5812/jjm.21776] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Cheraghsahar S, Kazemi S, Birjandi M, Yarahmadi M, Mahmoudi S, Mohammadi R, Sepahvand A. Otomycosis in Western Iran: Clinical and Mycological Aspects. Arch Clin Infect Dis 2017;In Press. [DOI: 10.5812/archcid.57287] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Ismail MT, Al-Kafri A, Ismail M. Otomycosis in Damascus, Syria: Etiology and clinical features. Curr Med Mycol 2017;3:27-30. [PMID: 29707671 DOI: 10.29252/cmm.3.3.27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
3 Swain SK, Behera IC, Sahu MC, Das A. Povidone iodine soaked gelfoam for the treatment of recalcitrant otomycosis - Our experiences at a tertiary care teaching hospital of eastern India. J Mycol Med 2018;28:122-7. [PMID: 29223643 DOI: 10.1016/j.mycmed.2017.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
4 Tasić-Otašević S, Golubović M, Đenić S, Ignjatović A, Stalević M, Momčilović S, Bojanović M, Arsić-Arsenijević V. Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia. J Mycol Med 2020;30:101011. [PMID: 32693980 DOI: 10.1016/j.mycmed.2020.101011] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Westby D, O'Connell N, Powell J, Fenton JE. The changing nature of paediatric otomycosis in the mid-west of Ireland. J Laryngol Otol 2020;134:592-6. [PMID: 32713390 DOI: 10.1017/S0022215120001164] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Salari S, Ayatollahi Mousavi SA, Hadizadeh S, Izadi A. Epidemiology of dermatomycoses in Kerman province, southeast of Iran: A 10-years retrospective study (2004-2014). Microb Pathog 2017;110:561-7. [PMID: 28757272 DOI: 10.1016/j.micpath.2017.07.043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
7 Aboutalebian S, Mahmoudi S, Mirhendi H, Okhovat A, Abtahi H, Chabavizadeh J. Molecular epidemiology of otomycosis in Isfahan revealed a large diversity in causative agents. J Med Microbiol 2019;68:918-23. [PMID: 31063125 DOI: 10.1099/jmm.0.000985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Gharaghani M, Halvaeezadeh M, Ali Jalaee G, Taghipour S, Kiasat N, Zarei Mahmoudabadi A. Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran. Curr Med Mycol 2020;6:18-22. [PMID: 33628977 DOI: 10.18502/CMM.6.2.2696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Sabz G, Gharaghani M, Mirhendi H, Ahmadi B, Gatee MA, Sisakht MT, Hemati A, Mohammadi R, Taghavi J, Nouripour-Sisakht S. Clinical and microbial epidemiology of otomycosis in the city of Yasuj, southwest Iran, revealing Aspergillus tubingensis as the dominant causative agent. J Med Microbiol 2019;68:585-90. [PMID: 30801244 DOI: 10.1099/jmm.0.000948] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
10 Mahdavi Omran S, Yousefzade Z, Khafri S, Taghizadeh-Armaki M, Kiakojuri K. Effect of combination therapy with ceftizoxime and clotrimazole in the treatment of otomycosis. Curr Med Mycol 2018;4:18-23. [PMID: 30186989 DOI: 10.18502/cmm.4.1.30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kiakojuri K, Rajabnia R, Mahdavi Omran S, Pournajaf A, Karami M, Taghizadeh Armaki M. Role of Clotrimazole in Prevention of Recurrent Otomycosis. Biomed Res Int 2019;2019:5269535. [PMID: 31950041 DOI: 10.1155/2019/5269535] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Kiakojuri K, Armaki MT, Rajabnia R, Pournajaf A, Karami M, Khademian A, Omran SM. Outer Ear Infections in Iran: A Review. Open Access Maced J Med Sci 2019;7:1233-40. [PMID: 31049113 DOI: 10.3889/oamjms.2019.176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Kamali Sarwestani Z, Hashemi SJ, Rezaie S, Gerami Shoar M, Mahmoudi S, Elahi M, Bahardoost M, Tajdini A, Abutalebian S, Daie Ghazvini R. Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients. J Mycol Med 2018;28:279-84. [PMID: 29540288 DOI: 10.1016/j.mycmed.2018.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
14 Mofatteh MR, Naseripour Yazdi Z, Yousefi M, Namaei MH. Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment. Braz J Otorhinolaryngol 2018;84:404-9. [PMID: 28549873 DOI: 10.1016/j.bjorl.2017.04.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
15 Lam P, Lee KK, Kok SH, Gambari R, Lam K, Ho C, Ma X, Lo Y, Wong W, Dong Q, Bian Z, Chui C. Antifungal study of substituted 4-pyridylmethylene-4′-aniline Schiff bases. RSC Adv 2016;6:104575-81. [DOI: 10.1039/c6ra20186e] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]